Cc1ccc(C(=O)Nc2nnc(SCc3cc(=O)c4c(C)ccc(C)c4[nH]3)s2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?